55
Views
19
CrossRef citations to date
0
Altmetric
Original Articles

The promise of atypical antipsychotics

Fewer side effects mean enhanced compliance and improved functioning

, MD, MPH & , MD, PhD
Pages 49-63 | Published online: 30 Jun 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Michael Rosenbluth & Mark Sinyor. (2012) Off-label use of atypical antipsychotics in personality disorders. Expert Opinion on Pharmacotherapy 13:11, pages 1575-1585.
Read now
Ari Eckman & Adrian Dobs. (2008) Drug-induced gynecomastia. Expert Opinion on Drug Safety 7:6, pages 691-702.
Read now
Leslie Citrome & Betty Vreeland. (2008) Schizophrenia, Obesity, and Antipsychotic Medications: What Can We Do?. Postgraduate Medicine 120:2, pages 18-33.
Read now
. (2008) Supplement Issue. Annals of Clinical Psychiatry 20:sup1, pages 1-32.
Read now
Pei-xian Mao, Yi-lang Tang, Zhi-min Wang, Feng Jiang, Charles F. Gillespie & Zhuo-ji Cai. (2007) Antipsychotic drug use in 503 Chinese inpatients with schizophrenia. International Journal of Psychiatry in Clinical Practice 11:1, pages 29-35.
Read now
Joseph F. Goldberg & Leslie Citrome. (2005) Latest therapies for bipolar disorder. Postgraduate Medicine 117:2, pages 25-36.
Read now

Articles from other publishers (13)

Kai Zhang, Shipan Miao, Yitan Yao, Yating Yang, Shengya Shi, Bei Luo, Mengdie Li, Ling Zhang & Huanzhong Liu. (2023) Efficacy and safety of prophylactic use of benzhexol after risperidone treatment. Heliyon 9:3, pages e14199.
Crossref
W. Wolfgang Fleischhacker & Alex Hofer. 2012. Handbuch der Psychopharmakotherapie. Handbuch der Psychopharmakotherapie 937 960 .
Pasquale De Fazio, Paolo Girardi, Giuseppe Maina, Massimo Carlo Mauri, Mauro Mauri, Palmiero Monteleone, Giulia Ida Perini, Giulio Perugi & Alessandro Rossi. (2010) Aripiprazole in Acute Mania and Long-Term Treatment of Bipolar Disorder. Clinical Drug Investigation 30:12, pages 827-841.
Crossref
Didier Meulien, Karin Huizar & Martin Brecher. (2010) Safety and tolerability of once‐daily extended release quetiapine fumarate in acute schizophrenia: pooled data from randomised, double‐blind, placebo‐controlled studies. Human Psychopharmacology: Clinical and Experimental 25:2, pages 103-115.
Crossref
M.A. Katzman, M. Vermani, L. Jacobs, M. Marcus, B. Kong, S. Lessard, W. Galarraga, L. Struzik & A. Gendron. (2008) Quetiapine as an adjunctive pharmacotherapy for the treatment of non-remitting generalized anxiety disorder: A flexible-dose, open-label pilot trial. Journal of Anxiety Disorders 22:8, pages 1480-1486.
Crossref
Joep Damen, Per-Olof Thuresson, Bart Heeg & Mickael Lothgren. (2012) A Pharmacoeconomic analysis of compliance gains on antipsychotic medications. Applied Health Economics and Health Policy 6:4, pages 189-197.
Crossref
W. Wolfgang Fleischhacker, Martina Hummer & Alex Hofer. 2008. Handbuch der Psychopharmakotherapie. Handbuch der Psychopharmakotherapie 847 872 .
Alex F. Manini, Dara Raspberry, Robert S. Hoffman & Lewis S. Nelson. (2007) QT prolongation and torsades de pointes following overdose of ziprasidone and amantadine. Journal of Medical Toxicology 3:4, pages 178-181.
Crossref
Leslie Citrome. (2007) Show Me the Evidence: Using Number Needed to Treat. Southern Medical Journal 100:9, pages 881-884.
Crossref
W. W. Fleischhacker & M. Hummer. (2006) Pharmakotherapie der SchizophreniePharmacotherapy for schizophrenia. Der Nervenarzt 77:S03, pages S77-S98.
Crossref
Mara BarretoDaniel Souery. (2006) Role of risperidone in the treatment of bipolar disorder. Future Neurology 1:5, pages 535-543.
Crossref
Sanjeev Ranjan, Prabha S Chandra, Santosh K Chaturvedi, Santosh C Prabhu & Arun Gupta. (2016) Atypical Antipsychotic–Induced Akathisia with Depression: Therapeutic Role of Mirtazapine. Annals of Pharmacotherapy 40:4, pages 771-774.
Crossref
M A Davies, V Setola, R T Strachan, D J Sheffler, E Salay, S J Hufeisen & B L Roth. (2005) Pharmacologic analysis of non-synonymous coding h5-HT2A SNPs reveals alterations in atypical antipsychotic and agonist efficacies. The Pharmacogenomics Journal 6:1, pages 42-51.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.